Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial
(Q84078596)
scientific article published on 07 May 2012
scientific article published on 07 May 2012
Language:
Current Data About
Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial
other details
description | scientific article published on 07 May 2012 |
External Links
(P356) |
10.1200/JCO.2011.39.9824
|
(P698) |
22565005
|